Scientific Publications Database

Article Title: A randomized phase II study of cabazitaxel (CAB) vs (ABI) abiraterone or (ENZ) enzalutamide in poor prognosis metastatic castration-resistant prostate cancer (mCRPC)
Authors: Chi, K. N.; Taavitsainen, S.; Iqbal, N.; Ferrario, C.; Ong, M.; Wadhwa, D.; Hotte, S. J.; Lo, G.; Tran, B.; Azad, A.; Wood, L.; Gingerich, J. R.; North, S.; Pezaro, C. V.; Ruether, D.; Sridhar, S. S.; Annala, M.; Bacon, J.; Wyatt, A. W.
Journal: ANNALS OF ONCOLOGY Volume 29
Date of Publication:2018
Abstract:
.